| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kan Zhang | |
| Guohua Shen | |||
| Zhiyun Jia | |||
| Pengwei Ren | |||
| You Lan | |||
| P2860 | cites work | PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer | Q24187743 |
| Cancer statistics, 2015 | Q27860576 | ||
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
| Diffusion-weighted MRI in the body: applications and challenges in oncology | Q31113294 | ||
| Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography | Q31151153 | ||
| Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT | Q33669779 | ||
| Dual-time-point FDG PET/CT: Is It Useful for Lymph Node Staging in Patients with Non-Small-Cell Lung Cancer? | Q33704517 | ||
| Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers | Q33914586 | ||
| Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model | Q34194318 | ||
| The diagnostic odds ratio: a single indicator of test performance | Q34276416 | ||
| Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging | Q36193014 | ||
| Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study | Q36225895 | ||
| Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study | Q36591008 | ||
| The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients | Q36755418 | ||
| Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient | Q36777017 | ||
| Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. | Q36963307 | ||
| The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery | Q37131297 | ||
| Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography | Q37493556 | ||
| Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis | Q37885139 | ||
| N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. | Q37934301 | ||
| Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis | Q41087156 | ||
| Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis. | Q41474160 | ||
| Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer | Q42905272 | ||
| Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? | Q43086231 | ||
| Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers | Q43271272 | ||
| Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer | Q43478685 | ||
| Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging | Q44318158 | ||
| Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients | Q44639914 | ||
| 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. | Q46017040 | ||
| Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC). | Q46133390 | ||
| The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax | Q46192851 | ||
| Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer | Q46371252 | ||
| Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease | Q46452298 | ||
| 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? | Q46945314 | ||
| STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients | Q46981366 | ||
| Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer | Q48673504 | ||
| Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer. | Q53078938 | ||
| Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? | Q53098941 | ||
| Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. | Q53153251 | ||
| Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma. | Q53168604 | ||
| Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study. | Q53190429 | ||
| Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. | Q53267582 | ||
| Incremental value of PET/CT Over CT for mediastinal nodal staging of non-small cell lung cancer: Comparison between patients with and without idiopathic pulmonary fibrosis. | Q53283281 | ||
| Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT. | Q53311656 | ||
| Positron-emission tomography for lung cancer in a tuberculosis-endemic region. | Q53344718 | ||
| Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. | Q53386784 | ||
| Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. | Q53426186 | ||
| Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. | Q53442891 | ||
| Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. | Q53503060 | ||
| FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? | Q60433923 | ||
| High-B-Value Diffusion-Weighted MRI in Colorectal Cancer | Q60601137 | ||
| Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy. | Q64999897 | ||
| Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients | Q79801720 | ||
| Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer | Q79972519 | ||
| Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results | Q79978488 | ||
| Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient | Q82717524 | ||
| A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer | Q83517552 | ||
| Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: the value of diffusion-weighted imaging | Q84136091 | ||
| The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer | Q84940362 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 |
| P304 | page(s) | e0173104 | |
| P577 | publication date | 2017-03-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis | |
| P478 | volume | 12 |
| Q50421393 | 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study. |
| Q55111752 | A dosimetric phantom study of thoracic radiotherapy based on three-dimensional modeling of mediastinal lymph nodes. |
| Q43667576 | Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis |
| Q42363300 | Correction: Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis |
| Q47108915 | Magnetic resonance imaging in precision radiation therapy for lung cancer |
Search more.